InvestorsHub Logo

newmedman

04/25/15 11:09 AM

#3337 RE: Gregwit #3329

Sativex news was already bad, but I understand your logic there.

the shorts gotta eat too. ;-)

I've said from the beginning that this is not a "pot play".

This is a pure, unadulterated, full fledged pharmaceutical company on the cutting edge of modern medicine.

People don't understand that GW has been at this for a decade. Hundreds of patents and multitudes of pages of published clinical trial research.

Otsuka funded Sativex, but we shareholders funded Epidolex.

Sativex pays big pharm.

Epidolex will pay us.
Just wait for those two little words to come from the FDA......

"fast track"

and just look what else they have in store for the next decade.




$GWPH